This compound is a biotin-PEG carboxylic acid derivative used in bioconjugation and pharmaceutical research. The biotin moiety (hexahydro-1H-thieno[3,4-d]imidazol-2-one) enables high-affinity binding to avidin or streptavidin, facilitating targeted delivery and purification applications. The pentaethylene glycol (PEG) chain provides enhanced water solubility, flexibility, and biocompatibility, while the terminal carboxylic acid group serves as a reactive site for amide coupling to amines on proteins, antibodies, or drug molecules. It is particularly useful in developing targeted therapeutics for oncology, such as streptavidin-biotin mediated antibody-drug conjugates or imaging agents, where stability, specificity, and controlled release are essential.